Follow
Jonathan Lellouche
Jonathan Lellouche
Clinical Laboratories Department, Laniado hospital
Verified email at laniado.org.il
Title
Cited by
Cited by
Year
Understanding the antibacterial mechanism of CuO nanoparticles: revealing the route of induced oxidative stress
G Applerot, J Lellouche, A Lipovsky, Y Nitzan, R Lubart, A Gedanken, ...
Small 8 (21), 3326-3337, 2012
5582012
Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis
A Grupper, N Sharon, T Finn, R Cohen, M Israel, A Agbaria, Y Rechavi, ...
Clinical Journal of the American Society of Nephrology 16 (7), 1037-1042, 2021
3232021
ZnO nanoparticle-coated surfaces inhibit bacterial biofilm formation and increase antibiotic susceptibility
G Applerot, J Lellouche, N Perkas, Y Nitzan, A Gedanken, E Banin
Rsc Advances 2 (6), 2314-2321, 2012
2552012
Antibiofilm activity of nanosized magnesium fluoride
J Lellouche, E Kahana, S Elias, A Gedanken, E Banin
Biomaterials 30 (30), 5969-5978, 2009
1932009
A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial
BD Huttner, V De Lastours, M Wassenberg, N Maharshak, A Mauris, ...
Clinical microbiology and infection 25 (7), 830-838, 2019
1512019
Sonochemical coatings of ZnO and CuO nanoparticles inhibit Streptococcus mutans biofilm formation on teeth model
M Eshed, J Lellouche, S Matalon, A Gedanken, E Banin
Langmuir 28 (33), 12288-12295, 2012
1502012
Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles
J Lellouche, A Friedman, R Lahmi, A Gedanken, E Banin
International journal of nanomedicine, 1175-1188, 2012
1452012
Antibacterial and antibiofilm properties of yttrium fluoride nanoparticles
J Lellouche, A Friedman, A Gedanken, E Banin
International journal of nanomedicine, 5611-5624, 2012
1042012
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial
Y Dickstein, J Lellouche, M Ben Dalak Amar, D Schwartz, A Nutman, ...
Clinical Infectious Diseases 69 (5), 769-776, 2019
992019
A Zn‐Doped CuO Nanocomposite Shows Enhanced Antibiofilm and Antibacterial Activities Against Streptococcus Mutans Compared to Nanosized CuO
M Eshed, J Lellouche, A Gedanken, E Banin
Advanced Functional Materials 24 (10), 1382-1390, 2014
922014
Improved antibacterial and antibiofilm activity of magnesium fluoride nanoparticles obtained by water-based ultrasound chemistry
J Lellouche, A Friedman, JP Lellouche, A Gedanken, E Banin
Nanomedicine: Nanotechnology, Biology and Medicine 8 (5), 702-711, 2012
912012
An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital
T Gottesman, R Fedorowsky, R Yerushalmi, J Lellouche, A Nutman
Infection prevention in practice 3 (1), 100113, 2021
762021
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: In vitro synergism is not associated with better clinical outcomes
A Nutman, J Lellouche, E Temkin, G Daikos, A Skiada, ...
Clinical Microbiology and Infection 26 (9), 1185-1191, 2020
662020
Novel triclosan‐bound hybrid‐silica nanoparticles and their enhanced antimicrobial properties
I Makarovsky, Y Boguslavsky, M Alesker, J Lellouche, E Banin, ...
Advanced Functional Materials 21 (22), 4295-4304, 2011
452011
Fourier transform infrared spectroscopy is a new option for outbreak investigation: a retrospective analysis of an extended-spectrum-beta-lactamase-producing Klebsiella …
N Rakovitsky, S Frenk, H Kon, D Schwartz, E Temkin, E Solter, S Paikin, ...
Journal of clinical microbiology 58 (5), 10.1128/jcm. 00098-20, 2020
372020
Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility
J Lellouche, D Schwartz, N Elmalech, MAB Dalak, E Temkin, M Paul, ...
Clinical Microbiology and Infection 25 (6), 711-716, 2019
292019
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria
AN Kristoffersson, V Rognås, MJE Brill, Y Dishon-Benattar, ...
Clinical Microbiology and Infection 26 (12), 1644-1650, 2020
282020
High rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patients
R Cohen, T Finn, F Babushkin, K Geller, H Alexander, M Shapiro, M Uda, ...
Infectious Diseases 54 (2), 134-144, 2022
262022
MgF 2 nanoparticle-coated teeth inhibit Streptococcus mutans biofilm formation on a tooth model
M Eshed, J Lellouche, E Banin, A Gedanken
Journal of Materials Chemistry B 1 (32), 3985-3991, 2013
252013
Detecting carbapenem-resistant Acinetobacter baumannii (CRAB) carriage: Which body site should be cultured?
A Nutman, E Temkin, J Lellouche, DB David, D Schwartz, Y Carmeli
Infection Control & Hospital Epidemiology 41 (8), 965-967, 2020
232020
The system can't perform the operation now. Try again later.
Articles 1–20